Standout Papers
Citation Impact
Citing Papers
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression
2005
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2020
2020 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Long-Term Estrogen Therapy Improves Vascular Function in Male to Female Transsexuals
1997
Trials of prostate-cancer screening are not worthwhile
2009
DHEA and DHEA‐S: A Review
1999
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Is dehydroepiandrosterone a hormone?
2005
Cushing's syndrome
2015 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer
2003
A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
1989
Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease
1999
Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice
1997 Standout
Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
1994
Enkephalin Inhibits Dopamine Synthesisin Vitroin the Median Eminence Portion of Rat Hypothalamic Slices
1988
Epigenetics in Cancer
2008 Standout
The Effects of Induced Hypogonadism on Arterial Stiffness, Body Composition, and Metabolic Parameters in Males with Prostate Cancer
2001
DNA‐Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates
2001
New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography–tandem mass spectrometry
2009
The role of the suckling stimulus in regulating pituitary prolactin mRNA in the rat
1989
Polycystic Ovary Syndrome
1995 Standout
Nrk, an X-linked Protein Kinase in the Germinal Center Kinase Family, Is Required for Placental Development and Fetoplacental Induction of Labor
2011 StandoutNobel
Visualizing Sexual Dimorphism in the Brain
2004 StandoutNobel
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Polycystic Ovary Syndrome
2005 Standout
Imaging Physiologic Dysfunction of Individual Hippocampal Subregions in Humans and Genetically Modified Mice
2000 StandoutNobel
Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans
2003
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
Major Depressive Disorder
2008 Standout
Treatment of hirsutism with the pure antiandrogen flutamide
1990
Regulation of prolactin secretion by adrenal steroids in oestrogen-treated ovariectomized rats: Participation of endogenous opioid peptides
1997
Bioavailability and Transport of Peptides and Peptide Drugs into the Brain
1997
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Changes in Plasma Lipoprotein and Apolipoprotein Composition in Relation to OralVersusPercutaneous Administration of Estrogen Alone or in Cyclic Association with Utrogestan in Menopausal Women
1991
Screening for Prostate Cancer in U.S. Men
2008
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
2010
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Cyclosporine
1989 Standout
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Production and Actions of Estrogens
2002 Standout
Cushing's syndrome
2006 Standout
Endogenous Opioids Mediate the Nocturnal Prolactin Surge in the Pregnant Rat*
1991
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
2010
Co-expression of Defective Luteinizing Hormone Receptor Fragments Partially Reconstitutes Ligand-induced Signal Generation
1997 StandoutNobel
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
2004
Circulating nucleic acids in plasma/serum
2007
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized Controlled Trial
2006
Systematic review and meta‐analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma
2002
Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing?s syndrome
2004
The Prolactin/Growth Hormone Receptor Family
1991
Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial1
2000
The immunocytochemical localization of enkephalin in the central nervous system of the rat
1981
Another role highlighted for estrogens in the male: Sexual behavior
2000
Effects of the Luteinizing Hormone-Releasing Hormone Agonist Leuprolide on Lipoproteins, Fibrinogen and Plasminogen Activator Inhibitor in Patients with Benign Prostatic Hyperplasia
1995
Iontophoresis of Morphine into the Arcuate Nucleus: Effects on Dopamine Concentrations in Hypophysial Portal Plasma and Serum Prolactin Concentrations*
1981
Site of action for β-endorphin-induced changes in plasma luteinizing hormone and prolactin in the ovariectomized rat
1984
Neurogenetic Adaptive Mechanisms in Alcoholism
1987 StandoutScience
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Arcuate Nucleus and Preoptic Area Involvement in Beta‐Endorphin‐lnduced Release of Prolactin in Conscious Ovariectomized Rats†
1989
Hormone receptor topology and dynamics: Morphological analysis using ferritin-labeled epidermal growth factor
1979 StandoutNobel
β-Adrenergic regulation of Sertoli cell adenylyl cyclase: desensitization by homologous hormone
1984
Selective decline in memory function among healthy elderly
1999
Screening for prostate cancer
2013
Effects of enkephalins and two enzyme resistant analogues on monoamine synthesis and metabolism in rat brain
1980 StandoutNobel
Enhanced Thyrotropin Response to Thyrotropin Releasing Hormone in Boys at Risk for Development of Alcoholism
1986
The opiomelanotropinergic neuronal and endocrine systems
1982
Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force
2008
The role of hormone receptors and GTP-regulatory proteins in membrane transduction
1980 StandoutNatureNobel
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study
1999
Granulosa Cells as Hormone Targets: The Role of Biologically Active Follicle-Stimulating Hormone in Reproduction
1989
Endogenous opiates block dopamine inhibition of prolactin secretion in vitro
1979 Nature
(d-Met2,Pro5)Enkephalinamide causes a decrease in plasma prolactin levels of lactating rats continuously suckled and an increase in those deprived of their litter
1984
Regulation of Prolactin Secretion at the Pituitary Level
1981
Double immunostaining reveals distinctions among opioid peptidergic neurons in the medial basal hypothalamus
1983
Genetic identification of HSD-1, a conserved steroidogenic enzyme that directs larval development inCaenorhabditis elegans
2008 StandoutNobel
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects
2005
Cellular and Molecular Mechanisms of Drug Dependence
1988 StandoutScience
Stimulation of prolactin secretion in the rat by α-neo-endorphin, β-neo-endorphin and dynorphin
1982
Cancer statistics, 2016
2016 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Induction of proenkephalin in tuberoinfundibular dopaminergic neurons by hyperprolactinemia: the role of sex steroids.
1995
Hormonal regulation of peptide receptors and target cell responses
1979 Nature
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
2002 Standout
Maturation of the Prolactin and Proopiomelanocortin Derived Peptide Responses to Ether Stress and Morphine: Neurochemical Analysis
1986
Differential effects of morphine, dopamine and prolactin administered iontophoretically on arcuate-ventromedial hypothalamic neurons
1983
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Cyclosporine Inhibits Testosterone Biosynthesis in the Rat Testis*
1987
Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model
1985 StandoutNatureNobel
15-Year Followup of a Population Based Prostate Cancer Screening Study
2009
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
2011
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
1990 StandoutScience
Adverse events associated with hormonal therapy for prostate cancer.
2005
Prostate Cancer Chemoprevention Agent Development: The National Cancer Institute, Division of Cancer Prevention Portfolio
2004
Screening for Prostate Cancer With the Prostate-Specific Antigen Test
2014
Prostate-Specific Antigen–Based Screening for Prostate Cancer
2018
Advances in Male Contraception
2008
Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer
1995
Biological Esterification of Steroids*
1998
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
1999 StandoutScience
Morphine- and opioid peptide-induced inhibition of the release of dopamine from tuberoinfundibular neurons
1979
Works of L. Cusan being referenced
Prostate cancer screening with PSA, DRE and TRUS.
1994
Changes in Plasma Lipoproteins During Various Androgen Suppression Therapies in Men With Prostatic Carcinoma: Effects of Orchiectomy, Estrogen, and Combination Treatment With Luteinizing Hormone-Releasing Hormone Agonist and Flutamide
1988
Screening decreases prostate cancer mortality: 11‐year follow‐up of the 1988 Quebec prospective randomized controlled trial
2004
Screening decreases prostate cancer death: First analysis of the 1988 Quebec Prospective Randomized Controlled Trial
1999
Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer
2000
Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in men
1989
Effects of flutamide and aminoglutethimide on plasma 5α-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate
1987
Analysis of the androgenic activity of synthetic “progestins” currently used for the treatment of prostate cancer
1987
Combination therapy in stage C and D prostatic cancer: rationale and five-year clinical experience
1987
Physiological Changes in Dehydroepiandrosterone Are Not Reflected by Serum Levels of Active Androgens and Estrogens But of Their Metabolites: Intracrinology
1997
Antifertility Effects of LHRH Agonists in the Male
1980
Long-Term Combined Androgen Blockade Alone for Localized Prostate Cancer.
1999
Evidence for a role of endorphins in stress- and suckling-induced prolactin release in the rat
1978
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
1988
Desensitization of FSH-Responsive Adenylyl Cyclase in Cultured Immature Sertoli Cells by Homologous Hormone
1982
Stimulatory Effect of Luteinizing Hormone and Human Chorionic Gonadotropin on Testicular Prolactin Receptor Levels
1980
Screening and treatment of localized prostate cancer decreases mortality: First analysis of the first prospective and randomized study on prostate cancer screening
1999
Inhibitory Effect of LHRH and Its Agonists on Testicular Gonadotrophin Receptors and Spermatogenesis in the Rat
1978
New hormonal treatment in cancer of the prostate: Combined administration of an LHRH agonist and an antiandrogen
1983
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.
1994
Potent prolactin and growth hormone releasing activity of more analogues of Met-enkephalin
1977 StandoutNatureNobel
INHIBITION OF SPERMATOGENESIS IN THE RAT BY TREATMENT WITH [D-Ala6,DES-GLY-NH210]LHRH ETHYLAMIDE
1978
Effect of an LHRH Agonist and hCG on Testicular Steroidogenesis in the Adult Rat
1980
Extremely rapid degradation of [3H] methionine-enkephalin by various rat tissues and
1977
Stimulation of prolactin release in the rat by intraventricular injection of β-end orphin and methionine-enkephalin
1977
Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent issues in the rat
1981
beta-Endorphin and met-enkephalins: their distribution, modulation by estrogens and haloperidol, and role in neuroendocrine control.
1980
History of LHRH agonist and combination therapy in prostate cancer
1996
Marked Decline in Serum Concentrations of Adrenal C19 Sex Steroid Precursors and Conjugated Androgen Metabolites During Aging
1997
Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
1996
Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial.
1993
Inhibitory Effect of a Luteinizing Hormone (LH)-Releasing Hormone Agonist on Rat Ovarian LH and Follicle-Stimulating Hormone Receptor Levels During Pregnancy
1978